Cargando…

The Clinical and Molecular Epidemiology of Noncarbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae: A Case-Case-Control Matched Analysis

BACKGROUND: Risk factors and outcomes associated with carbapenem-resistant Enterobacteriaceae (CRE) acquisitions are derived primarily from cohorts consisting of carbapenemase-producing (CP) strains. Worldwide epidemiology of non-CP-CRE is evolving, but controlled epidemiological analyses are lackin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouganim, Ruth, Dykman, Liana, Fakeh, Omar, Motro, Yair, Oren, Rivka, Daniel, Chen, Lazarovitch, Tzilia, Zaidenstein, Ronit, Moran-Gilad, Jacob, Marchaim, Dror
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443108/ https://www.ncbi.nlm.nih.gov/pubmed/32855986 http://dx.doi.org/10.1093/ofid/ofaa299

Ejemplares similares

496. Carbapenem-resistant Enterobacter: A Case-Case–Control Investigation
por: Cohen Mendel, Leore, et al.
Publicado: (2019)

Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae
por: Leibman, Violet, et al.
Publicado: (2015)

Towards a Definition for Health Care–Associated Infection
por: Friedman, N Deborah, et al.
Publicado: (2018)

Intra-abdominal Infections: The Role of Anaerobes, Enterococci, Fungi, and Multidrug-Resistant Organisms
por: Marcus, Gil, et al.
Publicado: (2016)

The MDR Upon Admission Score: Shortening Time to Initiation of Appropriate Antimicrobial Therapy in the Era of Resistance in the Community
por: Zilberman-Itskovich, Shani, et al.
Publicado: (2017)

Therapeutic Management of Pseudomonas aeruginosa Bloodstream Infection Non-Susceptible to Carbapenems but Susceptible to “Old” Cephalosporins and/or to Penicillins
por: Zaidenstein, Ronit, et al.
Publicado: (2018)

Serum Procalcitonin as a Marker for Infection in Patients with Acute Myocardial Infarction
por: Vitkon-Barkay, Itzhak, et al.
Publicado: (2017)

1150. Cleaning High Touch Surfaces of Patients’ Rooms: Make It Easier, and It Simply Gets Cleaner
por: Martin, Emily T, et al.
Publicado: (2018)

1204. The MDR Upon Admission Score for Shortening Time to Initiation of Appropriate Antimicrobial Therapy in the Era of Widespread Resistance to Antimicrobials
por: Chedid, Khalil, et al.
Publicado: (2018)

Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy
por: Eilertson, Brandon, et al.
Publicado: (2017)

Risk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258
por: Dhar, Sorabh, et al.
Publicado: (2016)

Epidemiology of Carbapenem-Resistant Enterobacteriaceae at a Long-term Acute Care Hospital
por: Chopra, Teena, et al.
Publicado: (2018)

Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study
por: Lazarovits, Gilad, et al.
Publicado: (2022)

Systematic Analysis of Mobile Genetic Elements Mediating β-Lactamase Gene Amplification in Noncarbapenemase-Producing Carbapenem-Resistant Enterobacterales Bloodstream Infections
por: Shropshire, W. C., et al.
Publicado: (2022)

Predicting Carbapenem-Resistant Enterobacteriaceae Carriage at the Time of Admission Using a Statewide Hospital Discharge Database
por: Lin, Michael Y, et al.
Publicado: (2019)

Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials
por: Alexander, Elizabeth L., et al.
Publicado: (2017)

A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant Enterobacteriaceae
por: Henig, Oryan, et al.
Publicado: (2017)

Increased Mortality Among Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Carriers Who Developed Clinical Isolates of Another Genotype
por: Chen, Wen Kai, et al.
Publicado: (2019)

In Vitro Activity of Essential Oils Against Gram-Positive and Gram-Negative Clinical Isolates, Including Carbapenem-Resistant Enterobacteriaceae
por: Patterson, Jan E, et al.
Publicado: (2019)

Antimicrobial Resistance or Delayed Appropriate Therapy—Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?
por: Lodise, Thomas P, et al.
Publicado: (2019)

Next-generation sequencing applications in clinical bacteriology
por: Motro, Yair, et al.
Publicado: (2017)

Prevalence and Characteristics of Carriage of Neisseria meningitidis Among Young Israeli Adults
por: Sofer-Sali, Noa, et al.
Publicado: (2022)

Cyber security threats in the microbial genomics era: implications for public health
por: Fayans, Iliya, et al.
Publicado: (2020)

2043. The “Resistance Calculator”: Refining Empiric Practices of Antimicrobials Prescription in the Era of Widespread Resistance
por: Zilberman-Itskovich, Shani, et al.
Publicado: (2019)

Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis
por: Muhammed, Maged, et al.
Publicado: (2017)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

Challenging diagnosis of Mycolicibacterium cosmeticum/canariasense infection: A case report and literature review
por: Grupel, Daniel, et al.
Publicado: (2023)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Comparative Effectiveness of Vancomycin vs. Metronidazole in Mild Clostridium difficile Infections, and Potential Impact on Subsequent Vancomycin-Resistant Enterococcus (VRE) Isolation
por: Youngster, Ilan, et al.
Publicado: (2017)

Treatment of Piperacillin-Tazobactam–Nonsusceptible/Ceftriaxone-Susceptible Infections With Carbapenem Versus Carbapenem-Sparing Antimicrobials
por: Cao, John, et al.
Publicado: (2023)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

Temporal Changes in the Skin Microbiome of Epidermolysis Bullosa Patients following the Application of Wound Dressings
por: Horev, Amir, et al.
Publicado: (2023)

Brucellosis Outbreak Traced to Commercially Sold Camel Milk through Whole-Genome Sequencing, Israel
por: Bardenstein, Svetlana, et al.
Publicado: (2021)

Public and animal health risks associated with spillover of Brucella melitensis into dairy farms
por: Bardenstein, Svetlana, et al.
Publicado: (2023)

Four Cases of Carbapenem-Resistant Enterobacteriaceae Infection from January to March in 2014
por: Kim, So Ri, et al.
Publicado: (2015)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
por: Falagas, Matthew E., et al.
Publicado: (2014)

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
por: Morrill, Haley J., et al.
Publicado: (2015)

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae
por: Lavagnoli, Lilian Silva, et al.
Publicado: (2017)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b5lunf8tlhlgf7h7rkhko6s1ru